1,25Dihydroxy  ||| S:0 E:14 ||| NNP
vitamin  ||| S:14 E:22 ||| VBD
D ||| S:22 E:23 ||| NNP
( ||| S:23 E:24 ||| -LRB-
3 ||| S:24 E:25 ||| LS
)  ||| S:25 E:27 ||| -RRB-
improves  ||| S:27 E:36 ||| VBZ
titanium  ||| S:36 E:45 ||| JJ
implant  ||| S:45 E:53 ||| JJ
osseointegration  ||| S:53 E:70 ||| NN
in  ||| S:70 E:73 ||| IN
osteoporotic  ||| S:73 E:86 ||| JJ
rats  ||| S:86 E:91 ||| NNS
This  ||| S:91 E:96 ||| DT
study  ||| S:96 E:102 ||| NN
aimed  ||| S:102 E:108 ||| VBN
to  ||| S:108 E:111 ||| TO
investigate  ||| S:111 E:123 ||| VB
the  ||| S:123 E:127 ||| DT
effects  ||| S:127 E:135 ||| NNS
of  ||| S:135 E:138 ||| IN
1,25 ||| S:138 E:142 ||| NNP
( ||| S:142 E:143 ||| -LRB-
OH ||| S:143 E:145 ||| NNP
) ||| S:145 E:146 ||| -RRB-
( ||| S:146 E:147 ||| -LRB-
2 ||| S:147 E:148 ||| LS
) ||| S:148 E:149 ||| -RRB-
D ||| S:149 E:150 ||| NNP
( ||| S:150 E:151 ||| -LRB-
3 ||| S:151 E:152 ||| LS
)  ||| S:152 E:154 ||| -RRB-
on  ||| S:154 E:157 ||| IN
implant  ||| S:157 E:165 ||| JJ
osseointegration  ||| S:165 E:182 ||| NN
in  ||| S:182 E:185 ||| IN
osteoporotic  ||| S:185 E:198 ||| JJ
rats ||| S:198 E:202 ||| NNS
.  ||| S:202 E:204 ||| .
Twelve  ||| S:204 E:211 ||| CD
weeks  ||| S:211 E:217 ||| NNS
after  ||| S:217 E:223 ||| IN
bilateral  ||| S:223 E:233 ||| JJ
ovariectomy ||| S:233 E:244 ||| NN
,  ||| S:244 E:246 ||| ,
each  ||| S:246 E:251 ||| DT
rat  ||| S:251 E:255 ||| NN
had  ||| S:255 E:259 ||| VBD
2  ||| S:259 E:261 ||| CD
titanium  ||| S:261 E:270 ||| NN
screws  ||| S:270 E:277 ||| NNS
implanted  ||| S:277 E:287 ||| VBN
in  ||| S:287 E:290 ||| IN
the  ||| S:290 E:294 ||| DT
proximal  ||| S:294 E:303 ||| JJ
tibiae ||| S:303 E:309 ||| NN
.  ||| S:309 E:311 ||| .
All  ||| S:311 E:315 ||| DT
animals  ||| S:315 E:323 ||| NNS
were  ||| S:323 E:328 ||| VBD
then  ||| S:328 E:333 ||| RB
randomly  ||| S:333 E:342 ||| RB
divided  ||| S:342 E:350 ||| VBN
into  ||| S:350 E:355 ||| IN
2  ||| S:355 E:357 ||| CD
groups ||| S:357 E:363 ||| NNS
:  ||| S:363 E:365 ||| :
control  ||| S:365 E:373 ||| NN
( ||| S:373 E:374 ||| -LRB-
10  ||| S:374 E:377 ||| CD
rats ||| S:377 E:381 ||| NNS
)  ||| S:381 E:383 ||| -RRB-
and  ||| S:383 E:387 ||| CC
1,25 ||| S:387 E:391 ||| NNP
( ||| S:391 E:392 ||| -LRB-
OH ||| S:392 E:394 ||| NNP
) ||| S:394 E:395 ||| -RRB-
( ||| S:395 E:396 ||| -LRB-
2 ||| S:396 E:397 ||| LS
) ||| S:397 E:398 ||| -RRB-
D ||| S:398 E:399 ||| NNP
( ||| S:399 E:400 ||| -LRB-
3 ||| S:400 E:401 ||| LS
)  ||| S:401 E:403 ||| -RRB-
( ||| S:403 E:404 ||| -LRB-
10  ||| S:404 E:407 ||| CD
rats ||| S:407 E:411 ||| NNS
) ||| S:411 E:412 ||| -RRB-
.  ||| S:412 E:414 ||| .
1,25 ||| S:414 E:418 ||| FW
( ||| S:418 E:419 ||| -LRB-
OH ||| S:419 E:421 ||| NNP
) ||| S:421 E:422 ||| -RRB-
( ||| S:422 E:423 ||| -LRB-
2 ||| S:423 E:424 ||| LS
) ||| S:424 E:425 ||| -RRB-
D ||| S:425 E:426 ||| NNP
( ||| S:426 E:427 ||| -LRB-
3 ||| S:427 E:428 ||| LS
)  ||| S:428 E:430 ||| -RRB-
was  ||| S:430 E:434 ||| VBD
administered  ||| S:434 E:447 ||| VBN
through  ||| S:447 E:455 ||| IN
oral  ||| S:455 E:460 ||| JJ
gavage  ||| S:460 E:467 ||| NN
at  ||| S:467 E:470 ||| IN
0.1  ||| S:470 E:474 ||| CD
μg ||| S:474 E:476 ||| FW
/ ||| S:476 E:477 ||| FW
kg ||| S:477 E:479 ||| FW
/ ||| S:479 E:480 ||| FW
d ||| S:480 E:481 ||| FW
,  ||| S:481 E:483 ||| ,
and  ||| S:483 E:487 ||| CC
control  ||| S:487 E:495 ||| NN
animals  ||| S:495 E:503 ||| NNS
were  ||| S:503 E:508 ||| VBD
given  ||| S:508 E:514 ||| VBN
vehicle ||| S:514 E:521 ||| NN
.  ||| S:521 E:523 ||| .
Eight  ||| S:523 E:529 ||| CD
weeks  ||| S:529 E:535 ||| NNS
later ||| S:535 E:540 ||| RB
,  ||| S:540 E:542 ||| ,
tibiae  ||| S:542 E:549 ||| VBG
with  ||| S:549 E:554 ||| IN
screws  ||| S:554 E:561 ||| NNS
were  ||| S:561 E:566 ||| VBD
harvested  ||| S:566 E:576 ||| VBN
for  ||| S:576 E:580 ||| IN
μCT ||| S:580 E:583 ||| NNP
,  ||| S:583 E:585 ||| ,
histologic ||| S:585 E:595 ||| NN
,  ||| S:595 E:597 ||| ,
and  ||| S:597 E:601 ||| CC
biomechanical  ||| S:601 E:615 ||| JJ
analysis ||| S:615 E:623 ||| NN
.  ||| S:623 E:625 ||| .
Compared  ||| S:625 E:634 ||| VBN
with  ||| S:634 E:639 ||| IN
control ||| S:639 E:646 ||| NN
,  ||| S:646 E:648 ||| ,
1,25 ||| S:648 E:652 ||| NNP
( ||| S:652 E:653 ||| -LRB-
OH ||| S:653 E:655 ||| NNP
) ||| S:655 E:656 ||| -RRB-
( ||| S:656 E:657 ||| -LRB-
2 ||| S:657 E:658 ||| LS
) ||| S:658 E:659 ||| -RRB-
D ||| S:659 E:660 ||| NNP
( ||| S:660 E:661 ||| -LRB-
3 ||| S:661 E:662 ||| LS
)  ||| S:662 E:664 ||| -RRB-
increased  ||| S:664 E:674 ||| VBD
percent  ||| S:674 E:682 ||| NN
bone  ||| S:682 E:687 ||| NN
volume  ||| S:687 E:694 ||| NN
by  ||| S:694 E:697 ||| IN
96.0 ||| S:697 E:701 ||| CD
% ||| S:701 E:702 ||| NN
,  ||| S:702 E:704 ||| ,
percent  ||| S:704 E:712 ||| NN
osseointegration  ||| S:712 E:729 ||| NN
by  ||| S:729 E:732 ||| IN
94.4 ||| S:732 E:736 ||| CD
% ||| S:736 E:737 ||| NN
,  ||| S:737 E:739 ||| ,
mean  ||| S:739 E:744 ||| VBP
trabecular  ||| S:744 E:755 ||| JJ
number  ||| S:755 E:762 ||| NN
by  ||| S:762 E:765 ||| IN
112.5 ||| S:765 E:770 ||| CD
% ||| S:770 E:771 ||| NN
,  ||| S:771 E:773 ||| ,
mean  ||| S:773 E:778 ||| VBP
trabecular  ||| S:778 E:789 ||| JJ
thickness  ||| S:789 E:799 ||| NN
by  ||| S:799 E:802 ||| IN
51.8 ||| S:802 E:806 ||| CD
% ||| S:806 E:807 ||| NN
,  ||| S:807 E:809 ||| ,
trabecular  ||| S:809 E:820 ||| JJ
connective  ||| S:820 E:831 ||| JJ
density  ||| S:831 E:839 ||| NN
by  ||| S:839 E:842 ||| IN
38.0 ||| S:842 E:846 ||| CD
% ||| S:846 E:847 ||| NN
,  ||| S:847 E:849 ||| ,
and  ||| S:849 E:853 ||| CC
decreased  ||| S:853 E:863 ||| VBD
trabecular  ||| S:863 E:874 ||| JJ
separation  ||| S:874 E:885 ||| NN
by  ||| S:885 E:888 ||| IN
39.3 ||| S:888 E:892 ||| CD
%  ||| S:892 E:894 ||| NN
in  ||| S:894 E:897 ||| IN
μCT  ||| S:897 E:901 ||| JJ
analysis ||| S:901 E:909 ||| NN
.  ||| S:909 E:911 ||| .
The  ||| S:911 E:915 ||| DT
1,25 ||| S:915 E:919 ||| NNP
( ||| S:919 E:920 ||| -LRB-
OH ||| S:920 E:922 ||| NNP
) ||| S:922 E:923 ||| -RRB-
( ||| S:923 E:924 ||| -LRB-
2 ||| S:924 E:925 ||| LS
) ||| S:925 E:926 ||| -RRB-
D ||| S:926 E:927 ||| NNP
( ||| S:927 E:928 ||| -LRB-
3 ||| S:928 E:929 ||| LS
)  ||| S:929 E:931 ||| -RRB-
increased  ||| S:931 E:941 ||| VBD
bone  ||| S:941 E:946 ||| JJ
area  ||| S:946 E:951 ||| NN
density  ||| S:951 E:959 ||| NN
by  ||| S:959 E:962 ||| IN
1.2-fold  ||| S:962 E:971 ||| NNP
and  ||| S:971 E:975 ||| CC
bone-to-implant  ||| S:975 E:991 ||| JJ
contact  ||| S:991 E:999 ||| NN
by  ||| S:999 E:1002 ||| IN
1.5-fold  ||| S:1002 E:1011 ||| CD
in  ||| S:1011 E:1014 ||| IN
histomorphometry ||| S:1014 E:1030 ||| NN
,  ||| S:1030 E:1032 ||| ,
and  ||| S:1032 E:1036 ||| CC
increased  ||| S:1036 E:1046 ||| VBD
the  ||| S:1046 E:1050 ||| DT
maximal  ||| S:1050 E:1058 ||| JJ
push-out  ||| S:1058 E:1067 ||| JJ
force  ||| S:1067 E:1073 ||| NN
by  ||| S:1073 E:1076 ||| IN
2.0-fold  ||| S:1076 E:1085 ||| CD
in  ||| S:1085 E:1088 ||| IN
biomechanical  ||| S:1088 E:1102 ||| JJ
test ||| S:1102 E:1106 ||| NN
.  ||| S:1106 E:1108 ||| .
The  ||| S:1108 E:1112 ||| DT
1,25 ||| S:1112 E:1116 ||| NNP
( ||| S:1116 E:1117 ||| -LRB-
OH ||| S:1117 E:1119 ||| NNP
) ||| S:1119 E:1120 ||| -RRB-
( ||| S:1120 E:1121 ||| -LRB-
2 ||| S:1121 E:1122 ||| LS
) ||| S:1122 E:1123 ||| -RRB-
D ||| S:1123 E:1124 ||| NNP
( ||| S:1124 E:1125 ||| -LRB-
3 ||| S:1125 E:1126 ||| LS
)  ||| S:1126 E:1128 ||| -RRB-
improves  ||| S:1128 E:1137 ||| VBZ
implant  ||| S:1137 E:1145 ||| JJ
osseointegration  ||| S:1145 E:1162 ||| NN
in  ||| S:1162 E:1165 ||| IN
osteoporotic  ||| S:1165 E:1178 ||| JJ
rats ||| S:1178 E:1182 ||| NNS
.  ||| S:1182 E:1184 ||| .
